(2021). The Use of Faricimab for the Treatment of Wet age Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME). Alustath, 21(4), 373-373. doi: 10.52573/ipmj.2021.176975
. "The Use of Faricimab for the Treatment of Wet age Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)". Alustath, 21, 4, 2021, 373-373. doi: 10.52573/ipmj.2021.176975
(2021). 'The Use of Faricimab for the Treatment of Wet age Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)', Alustath, 21(4), pp. 373-373. doi: 10.52573/ipmj.2021.176975
The Use of Faricimab for the Treatment of Wet age Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME). Alustath, 2021; 21(4): 373-373. doi: 10.52573/ipmj.2021.176975


Journal Management System. Powered by ejournalplus.com